$SGRY
Surgery Partners, Inc.

2021 Q4 Form 10-Q Financial Statement

#000163883321000146 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $610.2M $559.2M $496.1M
YoY Change 11.29% 12.72% 9.76%
Cost Of Revenue $441.3M $413.3M $360.0M
YoY Change 13.1% 14.81% 1.95%
Gross Profit $168.9M $145.9M $136.1M
YoY Change 6.83% 7.2% 37.61%
Gross Profit Margin 27.68% 26.09% 27.43%
Selling, General & Admin $49.00M $48.90M $47.10M
YoY Change 5.38% 3.82% 14.04%
% of Gross Profit 29.01% 33.52% 34.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $22.70M $25.20M $24.10M
YoY Change -10.98% 4.56% 30.98%
% of Gross Profit 13.44% 17.27% 17.71%
Operating Expenses $59.50M $495.6M $477.6M
YoY Change -17.36% 3.77% 21.53%
Operating Profit $109.4M $63.60M $18.50M
YoY Change 27.06% 243.78% -68.64%
Interest Expense -$57.30M -$54.20M -$51.50M
YoY Change 12.8% 5.24% 12.69%
% of Operating Profit -52.38% -85.22% -278.38%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $54.70M $9.400M -$33.00M
YoY Change 29.31% -128.48% -348.12%
Income Tax $11.80M $1.200M $1.300M
% Of Pretax Income 21.57% 12.77%
Net Earnings -$100.0K -$22.90M -$61.60M
YoY Change -101.82% -62.82% 292.36%
Net Earnings / Revenue -0.02% -4.1% -12.42%
Basic Earnings Per Share -$0.28 -$1.46
Diluted Earnings Per Share -$1.181K -$0.28 -$1.46
COMMON SHARES
Basic Shares Outstanding 82.44M shares 80.73M shares 48.88M shares
Diluted Shares Outstanding 80.73M shares 48.88M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $389.9M $330.4M $450.0M
YoY Change 22.65% -26.58% 304.31%
Cash & Equivalents $389.9M $330.4M $450.0M
Short-Term Investments
Other Short-Term Assets $39.30M $28.80M $36.30M
YoY Change 43.43% -20.66% -27.25%
Inventory $61.10M $59.30M $50.90M
Prepaid Expenses $25.60M $29.80M $19.20M
Receivables $430.2M $393.4M $337.0M
Other Receivables $0.00 $0.00 $9.700M
Total Short-Term Assets $946.1M $841.7M $893.4M
YoY Change 18.04% -5.79% 72.5%
LONG-TERM ASSETS
Property, Plant & Equipment $953.8M $862.6M $812.6M
YoY Change 11.59% 6.15% 12.88%
Goodwill $3.912B $3.614B $3.345B
YoY Change 12.8% 8.04% -1.79%
Intangibles $43.70M
YoY Change -6.82%
Long-Term Investments $88.70M $89.60M $92.10M
YoY Change -2.1% -2.71% -1.29%
Other Assets $59.10M $50.30M $20.20M
YoY Change 118.89% 149.01% -94.13%
Total Long-Term Assets $5.172B $4.790B $4.420B
YoY Change 12.14% 8.38% 0.45%
TOTAL ASSETS
Total Short-Term Assets $946.1M $841.7M $893.4M
Total Long-Term Assets $5.172B $4.790B $4.420B
Total Assets $6.118B $5.632B $5.313B
YoY Change 13.01% 6.0% 8.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $124.9M $116.5M $90.30M
YoY Change 24.65% 29.01% 6.11%
Accrued Expenses $215.0M $203.7M $278.1M
YoY Change -3.76% -26.75% 22.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $60.40M $60.80M $61.10M
YoY Change -6.21% -0.49% 19.1%
Total Short-Term Liabilities $536.8M $540.5M $590.9M
YoY Change -3.59% -8.53% 54.89%
LONG-TERM LIABILITIES
Long-Term Debt $2.878B $2.792B $2.761B
YoY Change 3.08% 1.11% 14.91%
Other Long-Term Liabilities $87.00M $124.4M $124.9M
YoY Change -37.72% -0.4% -70.7%
Total Long-Term Liabilities $87.00M $124.4M $124.9M
YoY Change -37.72% -0.4% -70.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $536.8M $540.5M $590.9M
Total Long-Term Liabilities $87.00M $124.4M $124.9M
Total Liabilities $623.8M $664.9M $715.8M
YoY Change -10.44% -7.11% -11.39%
SHAREHOLDERS EQUITY
Retained Earnings -$502.7M -$502.6M
YoY Change 16.42%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.089B $756.3M $101.2M
YoY Change
Total Liabilities & Shareholders Equity $6.118B $5.632B $5.313B
YoY Change 13.01% 6.0% 8.04%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$100.0K -$22.90M -$61.60M
YoY Change -101.82% -62.82% 292.36%
Depreciation, Depletion And Amortization $22.70M $25.20M $24.10M
YoY Change -10.98% 4.56% 30.98%
Cash From Operating Activities $19.70M $14.90M $26.90M
YoY Change 121.35% -44.61% -52.72%
INVESTING ACTIVITIES
Capital Expenditures -$14.10M -$15.50M -$7.900M
YoY Change -6.62% 96.2% -57.07%
Acquisitions
YoY Change
Other Investing Activities -$175.9M -$85.50M $37.20M
YoY Change 119.6% -329.84% -7540.0%
Cash From Investing Activities -$190.0M -$101.0M $29.30M
YoY Change 99.58% -444.71% -255.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 229.8M -48.30M 67.50M
YoY Change -601.75% -171.56% -253.06%
NET CHANGE
Cash From Operating Activities 19.70M 14.90M 26.90M
Cash From Investing Activities -190.0M -101.0M 29.30M
Cash From Financing Activities 229.8M -48.30M 67.50M
Net Change In Cash 59.50M -134.4M 123.7M
YoY Change -145.04% -208.65% -2127.87%
FREE CASH FLOW
Cash From Operating Activities $19.70M $14.90M $26.90M
Capital Expenditures -$14.10M -$15.50M -$7.900M
Free Cash Flow $33.80M $30.40M $34.80M
YoY Change 40.83% -12.64% -53.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001638833
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37576
dei Entity Registrant Name
EntityRegistrantName
Surgery Partners, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3620923
dei Entity Address Address Line1
EntityAddressAddressLine1
310 Seven Springs Way, Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Brentwood
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37027
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
234-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SGRY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
82436720 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330400000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317900000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
393400000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
382200000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
59300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
56400000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
29800000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17600000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
28800000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
27400000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
841700000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
801500000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
254000000.0 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
189300000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
542100000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
544600000 USD
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3659300000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3514900000 USD
CY2021Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
89600000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
90300000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
320500000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
310100000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
128100000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
124800000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50300000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000000.0 USD
CY2021Q3 us-gaap Assets
Assets
5631600000 USD
CY2020Q4 us-gaap Assets
Assets
5413200000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
116500000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
100200000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73100000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
65400000 USD
CY2021Q3 sgry Medicare Accelerated Payments And Deferred Governmental Grants Current
MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
81800000 USD
CY2020Q4 sgry Medicare Accelerated Payments And Deferred Governmental Grants Current
MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
109800000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
208300000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
217000000.0 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60800000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
64400000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
540500000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
556800000 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2791900000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2792400000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
312400000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
300900000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
124400000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
139700000 USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
310400000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
306800000 USD
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
310000 shares
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
310000 shares
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
310000 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
310000 shares
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Redemption Value
RedeemableNoncontrollingInterestEquityPreferredRedemptionValue
0 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Redemption Value
RedeemableNoncontrollingInterestEquityPreferredRedemptionValue
434500000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
434500000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82458385 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82458385 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50461706 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50461706 shares
CY2021Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
800000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
500000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1306000000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
607900000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47900000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-61000000.0 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-502600000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-431800000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
756300000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
115600000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
795700000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
766500000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1552000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882100000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5631600000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5413200000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
559200000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
496100000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1614900000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1311800000 USD
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
162300000 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
141700000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
468700000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
398200000 USD
CY2021Q3 us-gaap Supplies Expense
SuppliesExpense
160100000 USD
CY2020Q3 us-gaap Supplies Expense
SuppliesExpense
142800000 USD
us-gaap Supplies Expense
SuppliesExpense
464900000 USD
us-gaap Supplies Expense
SuppliesExpense
382200000 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
56800000 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
46300000 USD
us-gaap Professional Fees
ProfessionalFees
169700000 USD
us-gaap Professional Fees
ProfessionalFees
138400000 USD
CY2021Q3 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
23400000 USD
CY2020Q3 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
21900000 USD
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
68800000 USD
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
64700000 USD
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
34100000 USD
CY2020Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
29200000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
98500000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
83900000 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
436700000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
381900000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1270600000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1067400000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25500000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25200000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76800000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73300000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25200000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69300000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2900000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8500000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7600000 USD
CY2021Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1900000 USD
CY2020Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-700000 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-2000000.0 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7100000 USD
CY2021Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
10200000 USD
CY2020Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
5400000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
24700000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
15800000 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
33500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
33500000 USD
CY2021Q3 sgry Grant Revenue
GrantRevenue
0 USD
CY2020Q3 sgry Grant Revenue
GrantRevenue
-9900000 USD
sgry Grant Revenue
GrantRevenue
20000000.0 USD
sgry Grant Revenue
GrantRevenue
33200000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
500000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9100000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1200000 USD
CY2021Q3 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-500000 USD
CY2020Q3 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
0 USD
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-3300000 USD
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-1700000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
495600000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
477600000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2100000 USD
us-gaap Operating Expenses
OperatingExpenses
1427500000 USD
us-gaap Operating Expenses
OperatingExpenses
1225100000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
63600000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
18500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
187400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
86700000 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-54200000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-51500000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-160900000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-147800000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9400000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-33000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
26500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-61100000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14500000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
8200000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-34300000 USD
us-gaap Profit Loss
ProfitLoss
27800000 USD
us-gaap Profit Loss
ProfitLoss
-46600000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31100000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
27300000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
98600000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
75000000.0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-61600000 USD
us-gaap Net Income Loss
NetIncomeLoss
-70800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121600000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000000.0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10300000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
29200000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22900000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71600000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-81100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-150800000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.09
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.09
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80726000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48883000 shares
CY2021Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
2300000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20800000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68350000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48736000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80726000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48883000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68350000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48736000 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
8200000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-34300000 USD
us-gaap Profit Loss
ProfitLoss
27800000 USD
us-gaap Profit Loss
ProfitLoss
-46600000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6500000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3300000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
13100000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-14600000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14700000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31000000.0 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
24700000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
40900000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-61200000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
31100000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
27300000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
98600000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
75000000.0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16400000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-136200000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882100000 USD
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
100000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2800000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
10300000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
248300000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6400000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1105300000 USD
CY2021Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-4900000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3700000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
439700000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 USD
CY2021Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
5600000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22300000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1527300000 USD
CY2021Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-1200000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4100000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6500000 USD
CY2021Q3 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
37100000 USD
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
21800000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1552000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
983400000 USD
CY2020Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-13900000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2800000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9500000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-25200000 USD
CY2020Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
700000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
14900000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
923400000 USD
CY2020Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-9700000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3800000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9700000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7300000 USD
CY2020Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
1700000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20900000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
895900000 USD
CY2020Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-42300000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3000000.0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
10000000.0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3300000 USD
CY2020Q3 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
-30300000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
18800000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
800800000 USD
us-gaap Profit Loss
ProfitLoss
27800000 USD
us-gaap Profit Loss
ProfitLoss
-46600000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69300000 USD
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-12000000.0 USD
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-3100000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9900000 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-2000000.0 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7100000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
33500000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9100000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2300000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15300000 USD
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-200000 USD
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
1000000.0 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30300000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
29400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11900000 USD
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
-48500000 USD
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
141000000.0 USD
sgry Increase Decrease In Settlement Payments
IncreaseDecreaseInSettlementPayments
32200000 USD
sgry Increase Decrease In Settlement Payments
IncreaseDecreaseInSettlementPayments
0 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2100000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-19500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
238000000.0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27800000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
101000000.0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14200000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2500000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
48300000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-300000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-500000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-141700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6800000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
328400000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
197300000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
293000000.0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
428000000.0 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
4300000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
15800000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
11700000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8300000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
260900000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12700000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5100000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
97500000 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
82300000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2400000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
27300000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14400000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-300000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112500000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
357300000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
318200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93000000.0 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330400000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
450300000 USD
CY2021Q3 sgry Number Of Surgical Facilities Owned
NumberOfSurgicalFacilitiesOwned
127 surgical_facility
CY2021Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
31 state
CY2021Q3 sgry Number Of Surgical Facilities Owned Majority Interest
NumberOfSurgicalFacilitiesOwnedMajorityInterest
90 surgical_facility
CY2021Q3 sgry Number Of Surgical Facilities Owned Consolidated
NumberOfSurgicalFacilitiesOwnedConsolidated
110 surgical_facility
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
67000000 USD
sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
8000000 USD
CY2021Q3 sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
0 USD
sgry Grant Revenue
GrantRevenue
20000000 USD
CY2020 sgry Coronavirus Aid Reliefand Economic Security Act Cares Act Government Grant Received Accelerated Payments
CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments
120000000 USD
CY2021Q3 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
18000000 USD
sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
38000000 USD
CY2021Q3 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
80000000 USD
CY2020Q4 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
95000000 USD
CY2021Q3 sgry Deferred Employee Related Liabilities Current
DeferredEmployeeRelatedLiabilitiesCurrent
16900000 USD
CY2020Q4 sgry Deferred Employee Related Liabilities Current
DeferredEmployeeRelatedLiabilitiesCurrent
16900000 USD
CY2021Q3 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
4 surgical_facility
CY2021Q3 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
3 physician_practice
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
559200000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
496100000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1614900000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1311800000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
300000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3468000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
145700000 USD
sgry Goodwill Written Off Related To Sale Of Business Unit And Deconsolidation
GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation
100000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
3613600000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
306800000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
321000000.0 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
33800000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
19300000 USD
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
2400000 USD
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
-7900000 USD
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
32600000 USD
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
27700000 USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
310400000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
304700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.049
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4400000 USD
us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
-3000000 USD
sgry Effective Income Tax Rate Reconciliation Coronavirus Aid Relief And Economic Security Act Cares Act And Tax Settlement Amount
EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount
-6900000 USD
us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
5000000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
5000000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6300000 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2852700000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2856800000 USD
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
279900000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
281200000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
17200000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
16300000 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60800000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
64400000 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2791900000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2792400000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9100000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
56600000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
54900000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
20400000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
19000000.0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
18900000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
15700000 USD
sgry Finance Lease Cost
FinanceLeaseCost
39300000 USD
sgry Finance Lease Cost
FinanceLeaseCost
34700000 USD
CY2020Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1100000 USD
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
15000000.0 USD
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
12600000 USD
us-gaap Lease Cost
LeaseCost
110900000 USD
us-gaap Lease Cost
LeaseCost
102200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
55200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
49800000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
18000000.0 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
15700000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15800000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
12900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
44900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
53900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
10100000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
11500000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-26300000 USD
CY2021Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1537500000 USD
CY2020Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1200000000 USD
CY2021Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
17600000 USD
CY2021Q3 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
66600000 USD
CY2020Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
0 USD
CY2020Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
61000000.0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
5400000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
8600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-61600000 USD
us-gaap Net Income Loss
NetIncomeLoss
-70800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121600000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000000.0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10300000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
29200000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22900000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71600000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-81100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-150800000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80726000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80726000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48883000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48883000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68350000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68350000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48736000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48736000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.09
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
30.25
CY2020Q4 sgry Tax Receivable Agreement Liability Current
TaxReceivableAgreementLiabilityCurrent
21200000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40500000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39200000 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
37000000.0 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
24500000 USD
CY2021Q3 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
28500000 USD
CY2020Q4 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
16900000 USD
CY2021Q3 srt Payables To Customers
PayablesToCustomers
28000000.0 USD
CY2020Q4 srt Payables To Customers
PayablesToCustomers
20900000 USD
CY2021Q3 sgry Tax Receivable Agreement Liability Current
TaxReceivableAgreementLiabilityCurrent
21200000 USD
CY2021Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
32200000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
53100000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
62100000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
208300000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
217000000.0 USD
CY2021Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
22900000 USD
CY2020Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
21400000 USD
CY2020Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10500000 USD
CY2021Q3 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10500000 USD
CY2021Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
30700000 USD
sgry Collaborative Tax Agreement Projected Tax Savings Term
CollaborativeTaxAgreementProjectedTaxSavingsTerm
P5Y
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.24
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
43200000 USD
CY2021Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
43200000 USD
CY2021Q3 sgry Deferred Income Tax Liabilities Net Of Discount
DeferredIncomeTaxLiabilitiesNetOfDiscount
39900000 USD
CY2021Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2500000 USD
CY2020Q4 sgry Deferred Income Tax Liabilities Net Of Discount
DeferredIncomeTaxLiabilitiesNetOfDiscount
37000000 USD
CY2021Q3 sgry Deferred Income Tax Liabilities Net Of Discount Current
DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
21200000 USD
CY2020Q4 sgry Deferred Income Tax Liabilities Net Of Discount Current
DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
21200000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
559200000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
496100000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1614900000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1311800000 USD
CY2021Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
76400000 USD
CY2020Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
61100000 USD
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
225200000 USD
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
165800000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9400000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-33000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
26500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9900000 USD
CY2021Q3 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
10200000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
14400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-61100000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31100000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
27300000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
98600000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
75000000.0 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25200000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69300000 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-54200000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-51500000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-160900000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-147800000 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4100000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13400000 USD
CY2020Q3 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
7500000 USD
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
31000000.0 USD
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
30200000 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
33500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
33500000 USD
CY2021Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1900000 USD
CY2020Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-700000 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-2000000.0 USD
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7100000 USD
CY2021Q3 sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-2500000 USD
CY2020Q3 sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-1100000 USD
sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-4300000 USD
sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-4900000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
500000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9100000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 sgry Business Combination Gain Loss On Acquisition Escrow
BusinessCombinationGainLossOnAcquisitionEscrow
0 USD
CY2020Q3 sgry Business Combination Gain Loss On Acquisition Escrow
BusinessCombinationGainLossOnAcquisitionEscrow
0 USD
sgry Business Combination Gain Loss On Acquisition Escrow
BusinessCombinationGainLossOnAcquisitionEscrow
0 USD
sgry Business Combination Gain Loss On Acquisition Escrow
BusinessCombinationGainLossOnAcquisitionEscrow
800000 USD
CY2021Q3 us-gaap Unusual Or Infrequent Item Net Gain Loss
UnusualOrInfrequentItemNetGainLoss
500000 USD
CY2020Q3 us-gaap Unusual Or Infrequent Item Net Gain Loss
UnusualOrInfrequentItemNetGainLoss
0 USD
us-gaap Unusual Or Infrequent Item Net Gain Loss
UnusualOrInfrequentItemNetGainLoss
500000 USD
us-gaap Unusual Or Infrequent Item Net Gain Loss
UnusualOrInfrequentItemNetGainLoss
0 USD
CY2021Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
76400000 USD
CY2020Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
61100000 USD
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
225200000 USD
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
165800000 USD
CY2021Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
10200000 USD
CY2020Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
5400000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
3700000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1200000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2021Q3 us-gaap Assets
Assets
5631600000 USD
CY2020Q4 us-gaap Assets
Assets
5413200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27800000 USD

Files In Submission

Name View Source Status
0001638833-21-000146-index-headers.html Edgar Link pending
0001638833-21-000146-index.html Edgar Link pending
0001638833-21-000146.txt Edgar Link pending
0001638833-21-000146-xbrl.zip Edgar Link pending
a2021q3exhibit311.htm Edgar Link pending
a2021q3exhibit312.htm Edgar Link pending
a2021q3exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgry-20210930.htm Edgar Link pending
sgry-20210930.xsd Edgar Link pending
sgry-20210930_cal.xml Edgar Link unprocessable
sgry-20210930_def.xml Edgar Link unprocessable
sgry-20210930_htm.xml Edgar Link completed
sgry-20210930_lab.xml Edgar Link unprocessable
sgry-20210930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending